
Healthcare / Pharmaceuticals · NSE
Medistep Healthcare Limited, established in June 2023, is a pharmaceutical company involved in the production and trading of a variety of health and wellness products, including sanitary pads, energy powders, pharmaceutical and nutraceutical items, intimate care products, and surgical supplies. Focused on quality and growth, the company aims to expand its offerings as a public, non-government entity. As of December 30, 2024, it reported annualized revenue of ₹45 crore and a profit of ₹4.08 crore. The company had nine full-time employees, while additional labor needs are met through daily wage workers, with no contractual staff.
Price Band
₹43
Issue Size
₹16.10 Cr
Lot Size
3000 shares
GMP
+18.6%
Est. Listing
₹51
at current GMP
Subscribed
382.23x
overall
Open
8 Aug 2025
Close
12 Aug 2025
Allotment
13 Aug 2025
Refund
14 Aug 2025
Demat Credit
15 Aug 2025
Listing
18 Aug 2025
Overall Subscription
382.23x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
289.26x
High Net-Worth
Retail (RII)
461.17x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | — | 24,663,000 | 0.00x |
| NIB | 1,776,000 | 513,726,000 | 289.26x |
| RETAIL | 1,779,000 | 820,428,000 | 461.17x |
| Total | 3,555,000 | 1,358,817,000 | 382.23x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| QIB | — | 37 | 0.00x |
| NIB | — | 29,373 | 0.00x |
| RETAIL | 296 | 136,738 | 461.95x |
| Total Applications | 296 | 166,148 | 561.31x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Medistep Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹16.1 Crores. The shares are offered at a price band of ₹43 to ₹43 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 3000 shares (approx. ₹1,29,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Cameo Corporate Services Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-08-15, while un-allotted funds or UPI block mandates will be released on 2025-08-14.
The latest Grey Market Premium (GMP) for Medistep Healthcare Limited IPO is ₹8 per equity share. Based on the upper price band of ₹43 to ₹43 per equity share, the estimated listing price is ₹51 (+18.6% expected listing gain).
With a lot size of 3000 shares and current GMP of ₹8, the expected profit per application lot is approx ₹24,000 (+18.6% gain). Minimum application cost is approx ₹1,29,000.
The Medistep Healthcare Limited IPO aggregate issue size is ₹16.1 Crores with an equity price band set at ₹43 to ₹43 per equity share. The retail lot size is 3000 shares requiring a minimum capital outlay of approx. ₹1,29,000.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 382.23x (Retail: 461.17x, QIB: 0.00x, NII: 289.26x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Cameo Corporate Services Limited) and the BSE status verification website on or around 2025-08-13. Investors can verify status using PAN card or application number.
Medistep Healthcare Limited shares are scheduled to list on NSE on 2025-08-18.